The following is a summary of "Renal Denervation for Hypertension: From Innovation to Indication," published in the April 2025 issue of American Journal of Cardiology by Townsend et al. Hypertension ...

In a 2023 study published in The American Journal of Cardiology, Vaidya and colleagues applied the VEST algorithm to echocardiographic reports several months prior to evaluation at a PAH referral ...

Published Research Demonstrates the Value of BVA in Meeting Key Goal of Identifying Anemia in Heart Failure Patients Oak ...

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of ...

The Journal of the American College of Cardiology, is a peer-reviewed medical journal covering all aspects of cardiovascular disease, including original clinical studies, experimental ...

The following is a summary of “Lipid Management in US Commercial and Medicare Enrollees with Atherosclerotic Cardiovascular ...

Objective To estimate the dose–response associations between non-occupational physical activity and several chronic disease and mortality outcomes in the general adult population. Design Systematic ...

First, the 2022 American Heart Association/American College of Cardiology/Heart Failure Society of America HF guidelines provided recommendations, for the first time, on the clinical utility of ...

The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated Sid Patel, MD.

Cardiovascular disease remains a leading cause of morbidity and mortality in adults despite recent scientific advancements. Although people are living longer lives, there may be an adverse impact on ...